Our Health Library information does not replace the advice of a doctor. Please be advised that this information is made available to assist our patients to learn more about their health. Our providers may not see and/or treat all topics found herein.

Rh disease

Rh disease is a serious pregnancy problem that can affect a baby (fetus) with Rh-positive blood if the mother has Rh-negative blood. Because their blood types don't match, the mother's immune system will make antibodies that cause the fetus's red blood cells to be destroyed. This can lead to anemia, jaundice, and dangerous swelling.

Rh disease is also called hemolytic disease of the newborn or erythroblastosis fetalis.

Rh disease is the result of Rh sensitization, which causes the Rh-negative mother to make antibodies that attack the fetus's Rh-positive red blood cells. The more red blood cells are destroyed, the worse the effect on the fetus. In severe cases, the baby may die before or after birth.

Rh sensitization usually happens during childbirth, so a fetus in a first pregnancy may not have Rh disease. But each future Rh-positive fetus will be at risk, and Rh disease tends to be worse with each Rh-positive pregnancy.

In some cases, a fetus in a first pregnancy does have Rh disease. This can happen if the mother was Rh sensitized during a miscarriage, abortion, or ectopic pregnancy or because of a test that causes bleeding in the uterus during pregnancy, such as an amniocentesis or chorionic villus sampling. A blood test can show if a woman has Rh sensitization and whether her baby is at risk.

Treatment for Rh disease depends on how severe the disease is, which can be checked with regular testing throughout the pregnancy. A fetus with mild Rh disease may not need any special treatment. One who is more severely affected may need to have a blood transfusion while still in the uterus and to be delivered early.

A woman with Rh sensitization is likely to be cared for by a high-risk pregnancy specialist (perinatologist).

Current as of: April 30, 2024

Author: Ignite Healthwise, LLC Staff

Clinical Review Board
All Ignite Healthwise, LLC education is reviewed by a team that includes physicians, nurses, advanced practitioners, registered dieticians, and other healthcare professionals.

Dear patient

I am excited to announce that I will be relocating my practice to Houston Methodist DeBakey Cardiology Associates. Starting November 4, 2024, my new address will be:

5115 Fannin, Suite 801
Houston, TX 77004

Please note that my phone number and fax number will also change to the following:
24-Hour Telephone: 713-441-1100
Fax: 713-790-2643
Clinical Support Telephone (M-F, 8-5): 713-441-3515

I am excited about caring for you in my new office and hope you will make the transition with me. I will also continue to refill your medications as I have in the past. To assist, please provide your pharmacy with my new contact information.

Please consider checking your prescription refills to verify that you have enough medication on hand to last you until your next visit. Please note that your medical records will remain at my former office until you authorize their transfer. If you choose for me to continue providing your medical care, please complete and sign the enclosed “Authorization for Release of Medical Records” form and fax it to 713-790-2643. Once we receive your authorization, we will be happy to process the request for you.

Thank you for entrusting me with your medical care. My new team and I are dedicated to making this transition as seamless as possible. For help scheduling an appointment and transitioning your care, please call my new office number above.

I look forward to continuing your care at my new location.

Sincerely,
Gopi A. Shah, MD

Dear patient

Dr. Albert Raizner, Dr. Michael Raizner, and Dr. Mohamed El-Beheary are excited to announce that our practice, Interventional Cardiology Associates, will merge with Houston Cardiovascular Associates on November 1, 2024.

Our new offices are similarly located in Houston, near the Texas Medical Center and in Sugar Land. Our in-hospital care will continue at Houston Methodist Hospital in the Texas Medical Center and Houston Methodist Sugar Land Hospital. Importantly, our new offices expand our services with state-of-the-art equipment and amenities. Our core values will always be, as they began over 40 years ago when Dr. Albert Raizner founded ICA:

Integrity – Compassion – Accountability

Our new address and contact information are:

Your medical records are confidential and remain available at our new locations. We consider it a privilege to serve as your cardiologists and look forward to your continuing with us. However, should you desire to transfer to another physician, you may request a copy of your records by contacting us at our new addresses and phone numbers listed above.

We thank you for your trust and loyalty. As always, we will continue to be here to take care of you. Please do not hesitate to contact us if you have any questions or concerns.

Sincerely,

Dr. Albert Raizner,
Dr. Michael Raizner,
Dr. Mohamed El-Beheary